dr. jeffery s. weber on sequencing of nivolumab, ipilimumab in metastatic melanoma
Published 7 years ago • 189 plays • Length 1:28Download video MP4
Download video MP3
Similar videos
-
1:44
dr. jeffrey weber on optimal therapy sequences in advanced melanoma
-
1:55
dr. jeffrey weber on ipilimumab for melanoma
-
2:10
dr. weber on the toxicity profile of nivolumab versus ipilimumab for melanoma
-
2:05
dr. jeffrey weber explores nivolumab in advanced melanoma
-
2:18
dr. jeffrey weber on checkmate-064 trial for advanced melanoma
-
1:15
dr. weber on nivolumab in the adjuvant setting for melanoma
-
1:22
dr. weber on nivolumab versus chemotherapy in advanced melanoma
-
7:00
metastatic melanoma: the immunotherapy approach
-
0:49
dr. weber on emerging therapies in melanoma
-
1:21
dr. jeffrey weber on potential breakthrough "cures" in melanoma
-
7:08
the value of ipi/nivo in treating metastatic melanoma
-
5:30
jeffrey s weber, asco 2018 – resected stage iii melanoma and the checkmate 238 trial
-
1:03
dr. weber on risk and benefits with immunotherapy combos in melanoma
-
7:34
adjuvant therapy for melanoma: nivolumab, pembrolizumab, ipilimumab, dabrafenib and trametinib
-
2:05
dr. weber on adjuvant approaches in stage iii melanoma
-
1:22
dr. sznol discusses the combination of ipilimumab and nivolumab in melanoma
-
2:06
dr. weber on next steps with pembrolizumab as melanoma treatment
-
0:59
dr. weber on the fda approval for fixed-dose of nivolumab
-
2:25
dr. weber on discontinuing immunotherapy in melanoma